Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Viemed Healthcare (VMD) FCF Margin (2018 - 2026)

Viemed Healthcare filings provide 8 years of FCF Margin readings, the most recent being 30.47% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 2527.0% to 30.47% in Q4 2025 year-over-year; TTM through Dec 2025 was 19.21%, a 1862.0% increase, with the full-year FY2025 number at 19.21%, up 1862.0% from a year prior.
  • FCF Margin hit 30.47% in Q4 2025 for Viemed Healthcare, up from 24.4% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 52.63% in Q3 2022 to a low of 27.5% in Q3 2021.
  • Median FCF Margin over the past 5 years was 9.92% (2021), compared with a mean of 10.29%.
  • Biggest five-year swings in FCF Margin: soared 8013bps in 2022 and later plummeted -4572bps in 2023.
  • Viemed Healthcare's FCF Margin stood at 6.23% in 2021, then soared by 229bps to 20.49% in 2022, then crashed by -223bps to 25.23% in 2023, then surged by 121bps to 5.2% in 2024, then soared by 486bps to 30.47% in 2025.
  • The last three reported values for FCF Margin were 30.47% (Q4 2025), 24.4% (Q3 2025), and 18.91% (Q2 2025) per Business Quant data.